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Background: The banking of biological samples raises a number of ethical issues in relation to the storage, export
and re-use of samples. Whilst there is a growing body of literature exploring participant perspectives in North
America and Europe, hardly any studies have been reported in Africa. This is problematic in particular in light of the
growing amount of research taking place in Africa, and with the rise of biobanking practices also on the African
continent. In order to investigate the perspectives of African research participants, we conducted a study with
research participants in a TB study in the Western Cape, South Africa.
Methods: Semi-structured interviews were conducted using an interview guide which drew on the most
prominent themes expressed in current literature on sample storage, re-use and exportation. Interviews were
conducted in Afrikaans and subsequently translated into English by the same interviewer. Interviews were
transcribed verbatim and analysed qualitatively.
Results: The results of our study indicate that the majority of participants were supportive of giving one-time
consent to the storage and re-use of their samples. The concept of research being for a “good cause” was a central
prerequisite. Additionally, a significant minority requested that they be re-contacted if a future use was not
stipulated on the original consent. There was also considerable variation in how participants understood the
concept of a ‘good cause’, with participants describing three distinct categories of research, of which two were
generally thought to constitute ‘good cause’ research. Research that was for-profit was considered to fall outside
the spectrum of ‘good cause’ research. Participants displayed confidence in the abilities of the researchers to make
future decisions regarding sample use, but seemed unaware of the role of ethics committees in either this process
or more generally.
Conclusions: Participants expressed a wide and complex range of views about issues of sample storage and re-use,
and they showed a great deal of trust in researchers. Participants’ willingness to have their samples stored and re-
used is consistent with findings from existing studies. However, in contrast to existing literature, participants were
generally not in favour of for-profit research. Further research needs to be done to explore these ideas in other
communities, both in South Africa and other countries.* Correspondence: gvs.psych@gmail.com
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Following the sequencing of the human genome,
advances in genetics have opened up a plethora of re-
search strategies to investigate disease [1]. Pivotal to such
strategies is the long-term storage of samples, either as
isolated collections or in centralised biobanks, and the
re-use of samples and data for multiple projects [2].
A number of ethical challenges have been identified in
relation to the long-term storage and secondary use of
samples and data. In particular, ethical questions about
the governance of such collections and the compatibility
of secondary use with informed consent have been iden-
tified and discussed [3,4]. Some authors have argued in
favour of a process where participants sign consent on
one occasion, thereby authorising the researchers to use
their sample for several subsequent projects. There are
different viewpoints about whether or not such broad
consent is sufficiently informed [4,5]. Those in favour
have argued that the purpose of informed consent is
chiefly to respect the autonomy of the patient, and that
broad consent does not compromise this aim [4]. On the
contrary, others have argued that broad consent subverts
the principle of good informed consent by providing lit-
tle to no information about ‘future use’ [5].
In addition to consent, another prominent concern
relates to the concept of sample ownership. Specifically, it
is unclear to what extent participants should be and are
able to retain rights to their donated samples [6]. The
issue becomes clouded even further when future usage
includes research that has the potential to generate profit.
Moving beyond the theoretical debate, a number of
studies have been conducted that examined the views of
research participants regarding the acceptability of long-
term sample storage and consent. In an extensive review
of the topic, Wendler found more than 80 % of respon-
dents in the vast majority of studies reviewed reported
that they would consent to donating a sample for use in
a biobank [7]. Additionally, in the six studies included in
the review that addressed the issue of informed consent,
between 79 – 95 % of participants were in favour of one-
time, general consent, and were happy to rely on ethics
committees to make further decisions regarding use.
It would therefore appear that there is broad public
support for research involving biobanks, but important
challenges remain [8,9]. For instance, what remains
unclear is how to best obtain informed consent for
long-term sample re-use when future uses are not cur-
rently known [10,11]. Furthermore, a drawback of this
literature is that the majority of research investigating
participants’ perspectives has focussed on populations
in the US and Europe. Data on the views of African
research participants remains scarce despite an increase
in the number of research projects taking place on the
continent [12,13]. Southern Africa is regarded as fertileground for a wide range of research endeavours due to
the enormous burden of infectious disease in the region,
highly skilled medical researchers and large numbers of
treatment naïve patients [14]. South Africa is positioned
at the epicenter of the HIV pandemic, and HIV research
as well as HIV biobanking is flourishing scientifically.
There are currently 1390 clinical trials registered on the
South African Clinical Trials Register hosted by the
Department of Health. Two years ago (2010) there were
946 trials registered [15]. This indicates a significant
growth of clinical trial research over the past 2 years.
We are aware of only two reported research studies
that investigate the perspectives of African research par-
ticipants regarding sample storage and re-use, in Egypt
[16] and in Uganda [17]. The Ugandan study (n = 343)
found that a large majority (95 %) of participants would
consent to their sample being re-used without additional
consent, subject to approval by an Institutional Review
Board (IRB). On the other hand, the study in Egypt
(n = 600) found that just under half (44.3 %) of the parti-
cipants felt that consent forms should include a separate
section relating to storage and future use of samples and
data. Both studies used quantitative sociological methods
to invite participant viewpoints. To our knowledge, no
qualitative research studies have been reported in Africa,
including Southern Africa. Considering the contextual
complexity of these issues, and the vast cultural and geo-
graphical diversity on the African continent, we believe
it is of paramount importance to seek the views of African
research participants on these issues. Our study aimed to
provide a preliminary exploration into these issues, spe-
cifically seeking to qualitatively explore the views of
research participants on sample storage and re-use.
Methods
In order to explore the views of South African research
participants on sample storage and re-use, we set out to
conduct a qualitative sociological research study with
participants in a current tuberculosis (TB) research pro-
ject in a high density, low-income urban area in the
Western Cape, South Africa. The aim of the TB study
was to detect potential biomarkers of protective immun-
ity in a high risk TB population. The TB study involved
the collection of blood and saliva samples on three occa-
sions over 2 years. The TB study participants were
healthy and close contacts of people who had been diag-
nosed with TB, and had all consented to donate samples
that would be stored in a biobank with the potential for
future use. By the time that we conducted our research,
the TB study site had enrolled approximately 500 parti-
cipants. For our study, we approached participants in
the TB study, and conducted semi-structured interviews
with 20 individuals. Participants were selected at random
with the assistance of the nurse who was acting as the
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participants who were still active in the study, and who
were due to have a follow-up visit in the near future. Re-
cruitment was done both by contacting participants tele-
phonically, or by requesting their involvement during
their follow-up visits.
The aim of the interviews was to collect participants’
viewpoints on issues of sample storage and re-use and to
examine the acceptability of these. In addition, viewpoints
regarding how informed consent for these practices could
be optimised were explored. The initial interview guide
was developed by the research team, and discussed with
an investigator of the TB project and with one of the pro-
ject nurses. The interview guide was tested with two sixth
year medical students to ensure that questions were clear
and that they followed a logical order. See Table 1 for a
summary of the interview guide.
Interviews were conducted in Afrikaans by the same
interviewer. The interviews were semi-structured, con-
sisting of between three and five questions related to
each theme, with specific prompts that were used as
needed. A total of 20 interviews were conducted, by
which stage preliminary analysis of the data suggested
that no new major themes were emerging. After formal
analysis of the data this view was confirmed, and no fur-
ther interviews were conducted.
Interviews were recorded and transcribed verbatim.
Coding was done chiefly by one researcher, in consult-
ation with the other two researchers on the team. Initial
coding of the data generated themes, which were
included in a second round of coding [18]. All three
members of the research team discussed the coding ofTable 1 Summary of themes explored in interviews
Sample storage
- Duration
- Method of storage






- Types of research




- Opinion about “one-time” consent
- Role of ethics committee
- Role of community leadersthe data. Relationships were established between themes
and hierarchies established based on input from all three
investigators. Analysis was done using QRS NVivo ver-
sion 9 [19]. Transcripts were coded in the language in
which they had been conducted, where after the quotes
that were selected for inclusion in this manuscript were
translated verbatim into English.
Approval was obtained from the Stellenbosch University
Health Research Ethics Committee (Ref N11/04/118).
Informed consent was obtained from all participants.
Results
Sixteen of the participants were female and 4 were male
which broadly reflects the gender bias that was present
in the TB study itself. All of the participants were
Afrikaans-speaking and of mixed ancestry. As such, this
study likely informs more on the views of people with
mixed ancestry than on any other segment of the popu-
lation in our study area. The average age of the partici-
pants was 34 years, ranging from 18 to 65. The mean
number of years of schooling was 10.5. This ranged from
participants who had only completed 4 years of schooling
to participants who had received tertiary education. The
mode was 9 years of schooling, which is consistent with
the minimum legal requirement for schooling in South
Africa. Fifteen of the 20 participants were unemployed.
Issues regarding storage
Participants were asked how they felt about the possibil-
ity that their specimens could be stored after the initial
round of tests had been conducted. Research partici-
pants generally seemed to be unconcerned about sample
storage. The most commonly cited reason given was that
once the sample had been donated, they would have no
use for it, and storage would not affect them.
Yes I accept that (the blood being stored), what am I
going to do with it, I can do nothing with that blood,
I can’t put it back in.
And,
It’s blood that’s already been drawn, so it won’t be an
issue for me. . .. It’s not something you can put back.
But most participants (17 of 20) indicated that they
would only consent to storage if samples would be stored
securely and only be accessible to the research staff.
Sample ownership
Some divergence of opinion arose when asking partici-
pants whether they viewed the sample as still being their
property. Two participants felt that the sample remained
theirs, and that they reserved the right to either request
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of the participants felt that the sample became the prop-
erty of the researchers.
No, I don’t want to have access anymore. It’s not mine
anymore. They are using it now.
However, although the majority of participants felt that
the sample was no longer their property, it was clear that
they did not feel that surrendering ownership meant that
they lost all their rights. For instance, some participants
insisted that if revenue were ever to be made from research
using their sample, they would want to be re-contacted to
discuss how they or the community would benefit.
The thing is I gave it to them specifically to experiment
with. I didn’t give it to them to make a profit.
Re-use and the “good cause”
Next, we asked participants for their views on sample
re-use. When asked about the possibility that their
donated samples could be re-used, all participants indi-
cated that they would consent to this. But many partici-
pants (19 out of 20) described some conditions for re-
use. Most notably, participants felt that the purpose of
sample re-use should be to support research that would
constitute a “good cause”.
Look, as long as it’s for a good cause (re-use), if it will,
how can I say, enrich people’s lives, then its okay.
The main condition for re-use to be for a ‘good cause’
seemed to be based on altruistic motivations.
Yes, they use it to the benefit of others. It’s not only
for me, because a person must not always think about
yourself. You must think maybe this can affect other
people also. . .
For 17 out of 20 research participants, altruism was
the main motivation to agree to participation in the TB
research study. Similarly, it was most commonly given
as a motivation for accepting sample re-use.
Considering the prominence of ideas about a good
cause as a requirement for sample re-use, we spent con-
siderable time exploring what participants would con-
sider a good cause. In the course of this exploration,
three distinct categories of use emerged.
Community benefit
The first category is where research was conducted that
could have a direct benefit for the community. The most
commonly cited example was that of research on tuber-
culosis, which is highly prevalent in the community.It’s actually to the benefit of others, because maybe in
your blood there is something specific they can see in
other people, and then they can prevent that this (TB
infection) happens again.
There were also examples where community benefit
was understood in a broader sense.
I mean, you are doing something [. . .] I see it this
way, if I can help with any medical research and it’s a
bit of blood, it not litres and litres, its fine with me
And
Like sometimes, it is maybe for cancer and things like
that, it’s for good purposes that they are going to use
it, and not for something else
One participant, however, was more sceptical about
the likelihood that any benefit would flow from research
to participants or their communities.
You can say, yes, this is for the community with the
TB problem, they will agree but at the end of the day,
all is said and done, they were pricked with needles by
people in white coats and they got nothing out of it
The same participant went on to describe what he
would consider to be an appropriate form of benefit.
But if they can get a small something out of it, you
know? Even if it’s just a letter to say thank you, the
study was a success, you know? A box of biscuits
maybe? That kind of thing.
This point of view was in contrast with that of most
other participants, who emphasised their positive view
of TB research as being a source of community benefit.Academic and institutional benefit
The second category of research for the good cause
was research that could be regarded as more academic
in nature – thus not something that would be of obvi-
ous direct benefit to the local community. Nine out of
20 participants would support this kind of re-use.
There appeared to be a sense amongst these partici-
pants that if they could contribute to scientific research,
even of a more abstract nature, then they would be
happy to do so.
Yes I will say that is okay. Why, because, he can go
ahead with his career (the researcher), and he wants
to progress, then I am not concerned.
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for sample re-use for research of a more academic nature,
they also expressed the hope that such research could be
beneficial to themselves or the community in the future.
For instance, one participant suggested that by contribut-
ing to academic research, the researcher would eventually
be in a position to cure a disease like a HIV. Another par-
ticipant hoped that by supporting the university, there
was an increased chance that they would be able to offer
scholarships to members of the community.
Research for commercial purposes
A third category of use, and one that respondents did
not consider to be an example of re-use for a good
cause, was research done for the purposes of making a
profit. All of the participants expressed concern with this
idea, and would not wish for their sample to be re-used
for such a purpose.
Respondent: If it is for the institution and entirely for
research [. . .] maybe they can buy new equipment or
whatever they need in the lab [. . .] then the number
of people I am helping multiplies, because then the
research can carry on, yes.
Interviewer: [. . . And] if it is something that could
lead to profit for a corporation?
Respondent: No, that is something completely
different. That won’t work at all.
Participants furthermore indicated scepticism about
whether or not they would be informed if any revenue
was made following the use of their samples.
In any case they aren’t going to tell me they are going
to do it. It is going to happen in secret. So, who is
going to tell me they have done this and invested in
that. It’s not as if they are going to come tell me.
Some participants considered that they would consent
if they were to receive a share of any profits. Other parti-
cipants again felt that profit could be justified if there
was some form of community re-investment. However,
it must be emphasised that this idea was largely foreign
to many of the participants, and it was at times difficult
to establish clear boundaries for when research was ac-
tually considered to be “for profit”. Therefore, our data
must be seen as pointing towards a focus for further in-
vestigation before conclusions can be drawn.
Re-use and keeping participants informed
In addition to constructing an in-depth understanding of
the contexts in which participants would regard re-useto be acceptable, the interviews also sought to examine
what respondents considered to be the most appropriate
way to obtain and maintain informed consent for sec-
ondary re-use and sample storage. All participants
favoured a one-time consent process, although two
broad sets of perspectives emerged when it came to the
details of how far this process could go. Some partici-
pants (5 out of 20), felt that all intended usage should be
specified at the outset, and that consent should be
renewed if a previously undescribed application was
being considered.
Yes, it’s still my blood and they must come ask me if
they want to do something else with it.
And,
Because, I mean, you can’t make a list of four things,
and then I sign and then you add another thing, do
you understand?
The second perspective was that of participants who
would be happy for their samples to be re-used for any
research that met the essential requirement of being for
a “good cause”. The reasons for this were varied – some
participants felt that sample re-use would make no dif-
ference to them, given that the sample had already been
collected. They seemed also concerned that they might
be unnecessarily troubled if they had to re-consent for
previously undefined uses.
No, I wouldn’t like to be re-contacted every time a
test is done to come sign a form, because I have
already donated the blood.
Other participants indicated to rely on the researchers’
specialist knowledge to decide on the appropriateness
and necessity of sample re-use.
Interviewer: And do you trust these people to decide
what is a “good cause”? You don’t feel they should
come to you and ask whether you feel it is a good
cause?
Respondent: No, I think it would depend on them.
They are more in the, it’s more in their field. They
know what to do.
And,
Yes, if it has to do with the community then it would
be very good (to have samples re-used), and if they
(the researchers) know it’s a good choice they are
making on my behalf then it will be fine with me.
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act in their best interests, and they considered them to
have good intentions.
Yes, and the reason is (for trusting) they do it with a
good heart. Look, they take the time to try and find
out where they can find solutions for TB and such
things
However, as illustrated earlier, there were instances
where participants felt that researchers would not always
act in their best interests, and trust was therefore not
unanimous amongst participants. Although attempts
were made to explore the issue of trust in ethics com-
mittees, none of the participants were aware of what an
ethics committee was, or indeed, that the research in
which they were participating had been subjected to eth-
ical review. This greatly limits the reliability of their
responses to this line of enquiry. Further research will
be required to understand how to balance these observa-
tions in the consent process in medical research in
South Africa.
Interestingly, 6 participants indicated that they would
like to be kept informed of sample use, even if they did
not require renewal of their consent.
They don’t need to get permission again, but I also
don’t want to be kept in the dark. I would appreciate
being kept up to date on what it is being used for, or
maybe they need more. Yes, I would like to know.
Discussion
Our study uncovered a wide range of views regarding
sample storage, re-use and consent required for these
two components of the research process. In general, par-
ticipants in our study seemed to be supportive of sample
storage and re-use, which is consistent with existing lit-
erature [4]. However, they did indicate that certain types
of re-use would be more acceptable than others. Of par-
ticular interest is that our participants appeared to have
little to say about the nature of the research. This is in
contrast to the survey by Abou-Zeid et al. [17], where
there was a significant difference between the number of
participants who would consent to research involving a
blood sample and those who would consent to genetic
research. Our participants appeared to have limited
understanding of what genetic research was, making it
impossible to reliably assess how they would feel about
such applications.
Participants were, however, able to differentiate re-
search practises based on their aims. We categorised the
examples given by research participants into three cat-
egories. These are: re-use for research that has a direct
health benefit for the community; research that wouldbe of benefit to the institution or field in a more general
sense; and ‘for profit’ research. The first two fall under
what one participant called ‘research for a good cause’, of
which participants were generally supportive. Research
in the third category, ‘for profit’, was not generally sup-
ported by research participants. This is an interesting
finding, particularly in the context of existing studies.
Abou-Zeid et al. reported that only 32.8 % of partici-
pants in their study would desire a share in any com-
mercial profits [16]. Although our question was slightly
different, it does suggest that the participants in our
sample had more concerns with for profit research than
has been reported in previous studies.
Our data suggests that participants were generally in
favour of a one-time consent procedure when donating
samples for storage and re-use, although a minority felt
that re-consent should be sought if the re-use was for a
purpose not initially specified. This is in slight contrast
to the findings of Wendler et al. in Uganda, who
reported that 95 % of participants would be happy not
to be re-contacted, as long as the re-use was approved
by an Institutional Review Board [17].
Participants based their preference for a one-time con-
sent on the perceived expertise of the researchers, and
on their expectation that researchers would act in their
best interest. Participants furthermore indicated that
they would not really be affected if samples were used
multiple times, once the sample had been taken, and
that it may be burdensome to be re-contacted for subse-
quent uses. When expressing confidence in the research-
ers’ good intentions, this seemed to relate more to the
personal characteristics of the researcher than to his or
her institution. This finding would suggest that relying
on ethics committees to make re-use decisions can be
problematic in a community where the focus of partici-
pants’ trusts is more specifically on the actual research-
ers. Comparing this finding to existing research is
problematic, since it is primarily quantitative in nature.
For example, although the study in Uganda found that
participants were in favour of institutional review boards
making further research decisions on their behalf, we
cannot be sure that participants fully understood the
concept of what an institutional review board was. In
the previously mentioned review by Wendler [7], the
comment is made that “Data from more than 33000
people around the world support offering individuals a
simple choice of whether or not their samples can be
used for research purposes, with the stipulation that an
ethics committee will decide the studies for which their
samples are used”. We would argue that if such an
approach is to be employed, further research would be
needed to investigate participants’ understanding of
research ethics review as a component of the research
process.
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informed about the research they are involved with, in a
way that was distinct from a second informed consent
procedure. This desire to be kept in formed is con-
sistent with findings from several other studies [7]. More
research needs to be done to assess the feasibility and
possible impact of these types of feedback in the South
African context, which on initial exploration appear to
have the potential to increase both participant trust
and satisfaction. This is particularly relevant in the case
of informing participants about the eventual benefits of
any research project, which can serve both to address
deficiencies of trust and misunderstandings about re-
search outcomes.
The primary limitation of our study is the fact that
participants appeared to be uninformed about several
aspects of the research process. In particular, this limited
our ability to explore two significant themes pertaining
to biobanking practises – specifically, sample export-
ation, and the use of samples for specific research types
(such as genetic research). Gaining well considered input
on these issues remains a important challenge for the fu-
ture. An additional limitation of our study is that we re-
port on a relatively specific subgroup. Further research
will be required to assess the degree to which the con-
cerns we identified are of relevance in the broader
population.
Conclusions
In conclusion, the results of our study serve to highlight
that fact that participants display a wide and complex
range of views regarding these issues. Broadly, partici-
pants appear to be in favour of having samples stored
and re-used for research that is for a “good-cause”, a cat-
egory to which for-profit research appeared to be the
only significant exclusion. How participants understood
“for-profit” was not clear, and represents an important
avenue for further research. Further research also needs to
be conducted in order to explore these ideas in different
communities, both in South Africa and other countries,
so as to improve our ability to align research practices
with the preferences of the population under study.
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